发明名称 |
Prevention and treatment of amyloidogenic disease |
摘要 |
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is Abeta peptide or an antibody thereto.
|
申请公布号 |
US2004228865(A1) |
申请公布日期 |
2004.11.18 |
申请号 |
US20040816380 |
申请日期 |
2004.03.31 |
申请人 |
NEURALAB LIMITED |
发明人 |
SCHENK DALE B. |
分类号 |
G01N33/50;A61K9/26;A61K33/06;A61K38/00;A61K38/17;A61K38/19;A61K38/28;A61K39/00;A61K39/39;A61K39/395;A61K47/02;A61K47/24;A61K47/34;A61P25/28;C07H21/04;C07K14/47;C07K16/18;C07K16/40;C12N15/09;G01N33/15;G01N33/53;G01N33/567;(IPC1-7):A61K39/395 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|